ArticleFrontiers in oncology2022

Integrated single-cell and transcriptome sequencing analyses determines a chromatin regulator-based signature for evaluating prognosis in lung adenocarcinoma.

Qingtong Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.